June 25, 2018
Rose
New York’s Medicaid program says Orkambi, a new drug to treat cystic fibrosis, is not worth the price. The case is being closely watched around the country.
from Health https://ift.tt/2twfjFv
June 25, 2018
Rose
Health, Health - The New York Times
No comments
Related Posts:
Scientists Question Medical Data Used in Second Coronavirus Study- Coronavirus Live Updates: Emergency Room Visits Dropped Sharply During Pandemic
- Tests for Coronavirus Vaccine Need This Ingredient: Horseshoe Crabs
- Benzodiazepines Tied to Higher Risk of Ectopic Pregnancy
- E-Bikes Are Having Their Moment. They Deserve It.
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment